Muhammad Khan Selected Research

brevilin A

1/2022	Sesquiterpene Lactones Attenuate Paclitaxel Resistance Via Inhibiting MALAT1/STAT3/ FUT4 Axis and P-Glycoprotein Transporters in Lung Cancer Cells.
1/2020	Brevilin A Inhibits STAT3 Signaling and Induces ROS-Dependent Apoptosis, Mitochondrial Stress and Endoplasmic Reticulum Stress in MCF-7 Breast Cancer Cells.
1/2020	Brevilin A induces ROS-dependent apoptosis and suppresses STAT3 activation by direct binding in human lung cancer cells.
1/2018	Brevilin A promotes oxidative stress and induces mitochondrial apoptosis in U87 glioblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muhammad Khan Research Topics

Disease

40	Neoplasms (Cancer) 06/2022 - 01/2011
12	Wounds and Injuries (Trauma) 05/2020 - 11/2017
10	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2017
9	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 09/2012
8	Adenocarcinoma 06/2022 - 03/2009
8	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2011
7	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2013
5	COVID-19 07/2022 - 01/2020
5	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2016
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
4	Infections 07/2022 - 03/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2018
4	Stomach Neoplasms (Stomach Cancer) 05/2019 - 01/2011
4	Hemorrhage 01/2019 - 04/2017
3	Diarrhea 04/2022 - 06/2017
3	Inflammation (Inflammations) 01/2022 - 06/2017
3	Body Weight (Weight, Body) 01/2022 - 01/2012
3	Liver Diseases (Liver Disease) 01/2022 - 01/2014
3	Necrosis 02/2021 - 01/2020
3	Chest Pain (Chest Pains) 05/2020 - 01/2015
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 12/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 05/2008
3	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 11/2017
3	Pulmonary Embolism 12/2018 - 01/2018
3	Adenocarcinoma of Lung 01/2018 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2009
3	Liver Neoplasms (Liver Cancer) 01/2017 - 01/2013
2	Osteoporosis 04/2022 - 01/2015
2	Dizziness (Lightheadedness) 04/2022 - 01/2015
2	Low Back Pain (Lumbago) 03/2022 - 07/2014
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 08/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2015
2	Frailty 12/2020 - 12/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2018
2	Sepsis (Septicemia) 11/2019 - 01/2017
2	Myocardial Infarction 04/2019 - 08/2010
2	Pancreatitis 01/2019 - 01/2017
2	Fever (Fevers) 01/2019 - 06/2017
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2018 - 12/2017
2	Heart Failure 01/2018 - 09/2015
2	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 10/2014
2	Carcinoma (Carcinomatosis) 07/2016 - 06/2013
2	Obesity 03/2016 - 01/2014
2	Glioma (Gliomas) 01/2015 - 09/2012
1	Vitamin D Deficiency 07/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2012
9	LactonesIBA 01/2022 - 01/2013
9	SesquiterpenesIBA 01/2022 - 01/2013
6	Pharmaceutical PreparationsIBA 06/2020 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	alantolactoneIBA 01/2022 - 09/2012
5	CaspasesIBA 01/2020 - 01/2012
4	brevilin AIBA 01/2022 - 01/2018
4	VaccinesIBA 01/2021 - 01/2020
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2012
4	Caspase 3 (Caspase-3)IBA 01/2018 - 06/2013
4	isoalantolactoneIBA 10/2014 - 01/2012
3	Biological ProductsIBA 01/2022 - 01/2015
3	CytokinesIBA 01/2022 - 08/2010
3	EnzymesIBA 01/2022 - 01/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2017
3	ProscillaridinIBA 01/2020 - 01/2018
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2018 - 11/2017
3	Therapeutic UsesIBA 06/2017 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 01/2015
2	Antiviral Agents (Antivirals)IBA 03/2021 - 03/2016
2	Monoclonal AntibodiesIBA 02/2021 - 01/2020
2	Bevacizumab (Avastin)FDA Link 02/2021 - 01/2021
2	Thalidomide (Thalomid)FDA Link 01/2021 - 05/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2020
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2020 - 01/2020
2	Cardiac GlycosidesIBA 01/2020 - 01/2018
2	pseudolaric acid BIBA 01/2020 - 01/2012
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2019 - 10/2014
2	Gemcitabine FDA Link 01/2019 - 05/2008
2	Hemoglobins (Hemoglobin)IBA 11/2017 - 02/2017
2	DEET (DET)IBA 06/2017 - 01/2017
2	deoxyelephantopinIBA 06/2017 - 01/2017
2	santamarineIBA 01/2017 - 01/2017
2	VitaminsIBA 01/2017 - 06/2013
2	TriterpenesIBA 07/2016 - 03/2016
2	SaponinsIBA 07/2016 - 03/2016
2	evodiamineIBA 01/2015 - 05/2012
2	magnololIBA 09/2013 - 04/2012
2	jaceosidinIBA 01/2012 - 01/2011
1	Vitamin D FDA LinkGeneric 07/2022

Therapy/Procedure

32	Therapeutics 01/2022 - 06/2008
12	Drug Therapy (Chemotherapy) 01/2022 - 03/2009
12	Radiotherapy 01/2022 - 04/2012
7	Length of Stay 01/2020 - 03/2016
4	Immunotherapy 01/2022 - 01/2020
3	Musculoskeletal Manipulations (Manipulative Therapy) 11/2015 - 07/2014
2	Blood Transfusion (Blood Transfusions) 12/2021 - 02/2017
2	Surgical Amputation (Amputations) 12/2020 - 01/2019
2	Tracheostomy 01/2020 - 01/2020
2	Resuscitation 01/2019 - 01/2019